increased use of spironolactone for heart failure is causing more hospitalizations and deaths

The increased use of spironolactone for heart failure is causing more hospitalizations and deaths.

The problem started a few years ago when a large well-respected study showed that spironolactone improved survival in patients with severe heart failure.

This was the Randomized Aldactone Evaluation Study (RALES).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote